FDA says opioid labels must include information about naloxone
WASHINGTON — The Food and Drug Administration announced Thursday that it would require drug manufacturers to include information about naloxone, the overdose-reversal medication, on the labels of opioid painkillers.
The move comes just weeks after the federal government released new data showing that U.S. drug overdose deaths reached an all-time high in 2019, surpassing the previous peak recorded two years earlier. More recently, the Covid-19 pandemic has led to another increase in overdose deaths as the unemployment rate has skyrocketed and Americans have lost access to health insurance and to many in-person health services like addiction clinics or syringe exchanges.
Read Original Article: FDA says opioid labels must include information about naloxone »
